ORIC FY 2020 Earnings — ORIC Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

ORICORIC Pharmaceuticals, Inc.

$1B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$74M

Net Income

-$74M

EPS (Diluted)

$-3.36

Cash Flow

Operating Cash Flow

-$45M

Free Cash Flow

-$46M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$299M

Total Liabilities

$9M

Stockholders' Equity

$290M

Cash & Equivalents

$78M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$1M	+100.0%
Operating Income	-$74M	-$29M	-159.7%
Net Income	-$74M	-$27M	-174.2%